(Q26853010)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

1 reference

1 reference

title

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

1 reference

1 reference

Helicobacter pylori infectious disease

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Xavier Calvet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

11

Javier P Gisbert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1

Sheila López-Góngora

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

5

Albert Villoria

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

6

Mireia Baylina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jordi Sanchez-Delgado

8

object named as

Jordi Sanchez-Delgado

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

7

Neus Muñoz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Victor García-Hernando

10

object named as

Victor García-Hernando

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

David Suarez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

1 reference

14 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

17 February 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

70

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

9

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

2447-2455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

Clinical practice. Helicobacter pylori infection

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Antibiotic-resistant Helicobacter pylori strains in Portuguese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Pretreatment antimicrobial-susceptibility testing in the eradication of H. pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Furazolidone combination therapies for Helicobacter pylori infection in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Efficacy of a multistep strategy for Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV155

7 January 2021

Identifiers

DOI

10.1093/JAC/DKV155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26078393%20AND%20SRC:MED&resulttype=core&format=json